“Mean Percentage Improvement in Psoriasis Area and Severity Index (PASI) Response and Absolute PASI Through 5 Years of Continuous Treatment With Guselkumab (GUS) in VOYAGE 1 ”, J of Skin, vol. 6, no. 2, p. s3, Mar. 2022, doi: 10.25251/skin.6.supp.3.